Similar to FASN, SCD has been strongly implicated in the development and progression of neoplastic disease including a neuroblastoma [28,56,57,58,59,60,61,62] that is also vulnerable to treatment with polyamine pathway inhibitors. The gene discussed is FASN; the disease is neuroblastoma.